EVERSANA — Vancomycin Importer Profile
Pharmaceutical Importer · #3 buyer for Vancomycin · $3.2M import value · 65 shipments · UNITED STATES · DGFT Verified
EVERSANA is the #3 importer of Vancomycin from India with $3.2M in import value and 65 verified shipments. EVERSANA holds a 2.3% market share in Vancomycin imports based in UNITED STATES. The company sources from 1 verified supplier across 20 formulations shipped to 2 countries. Overall, EVERSANA imports 12 pharmaceutical products worth $27.6M across 9 therapeutic categories.
EVERSANA — Vancomycin Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Vancomycin to EVERSANA?
Verified from 65 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| GLAND PHARMA LIMITED | $3.2M | 65 | 100.0% |
EVERSANA sources Vancomycin from 1 verified Indian supplier based on 65 customs records. The primary supplier is GLAND PHARMA LIMITED accounting for 100.0% of imports.
How Does EVERSANA Compare to Nearest Vancomycin Importers?
Buyers ranked immediately above and below #3 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 5 | DR.FRIEDRICH EBERTH ARZNEIMITTEL | GERMANY | $3.3M | 69 | $47.5K |
| 9 | MYLAN AUSTRALIA | AUSTRALIA | $2.8M | 55 | $50.0K |
| 3 | EVERSANA ★ | UNITED STATES | $2.1M | 42 | $50.0K |
| 8 | HANSE SERVICE INTERNATIONALE | GERMANY | $1.7M | 34 | $50.0K |
| 10 | EVERSANA EVERSANA | UNITED STATES | $950.0K | 19 | $50.0K |
EVERSANA ranks #3 among 743 Vancomycin importers from India. Average shipment value of $50.0K compared to the market average of $36.8K. The closest competitors by value are DR.FRIEDRICH EBERTH ARZNEIMITTEL and MYLAN AUSTRALIA.
Where Does EVERSANA Import Vancomycin To?
Destination countries from 65 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $3.0M | 61 | 94.0% |
| UNITED STATES OF AMERICA | $190.4K | 4 | 6.0% |
EVERSANA imports Vancomycin to 2 countries. The primary destination is UNITED STATES receiving 94.0% of shipments worth $3.0M.
What Vancomycin Formulations Does EVERSANA Import?
| Formulation | Value | Shipments |
|---|---|---|
| VANCOMYCIN HYDROCHLORIDE FOR INJECTION USP 1G/VIAL 20ML VIAL | $563.5K | 12 |
| VANCOMYCIN HCL FOR INJECTION USP 10G/VIAL,100ML VIAL | $534.2K | 11 |
| VANCOMYCIN HYDROCHLORIDE FOR INJECTION U | $300.0K | 6 |
| VANCOMYCIN HCL FOR INJECTION USP 10G/VIA | $250.0K | 5 |
| VANCOMYCIN HCL INJECTION 5G/VIAL, 100MLVIAL | $213.0K | 5 |
| VANCOMYCIN HCL INJECTION 5G/VIAL, 100ML | $200.0K | 4 |
| VANCOMYCIN HCL FOR INJECTION USP 10G/VIAL100ML VIAL | $200.0K | 4 |
| VANCOMYCIN HCL FOR INJECTION USP, 5G/VIAL, 100ML VIAL | $147.2K | 3 |
| VANCOMYCIN HCL FORINJECTION USP10G/VIAL, | $100.0K | 2 |
| VANCOMYCIN HCL FOR INJECTION USP 10G/VIAL,100ML VIALNOS | $100.0K | 2 |
EVERSANA imports 20 distinct Vancomycin formulations from India. The top formulation is VANCOMYCIN HYDROCHLORIDE FOR INJECTION USP 1G/VIAL 20ML VIAL with 12 shipments worth $563.5K.
Regulatory Requirements: Importing Vancomycin into United States
What EVERSANA and other importers must comply with to import Vancomycin from India
Regulatory Authority
U.S. Food and Drug Administration (FDA)
Approval Process for Generic Vancomycin
Abbreviated New Drug Application (ANDA) for generic drugs, requiring bioequivalence studies and compliance with 21 CFR. Indian manufacturing sites must pass FDA pre-approval inspection.
Typical timeline: 10–18 months for ANDA approval
GMP Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA prior to approval
Import Licence & Documentation
Drug Listing with FDA; Import Alert screening; Customs entry via FDA PREDICT system
Labeling & Packaging
US-specific labeling per 21 CFR 201 including NDC number, lot, expiry, dosage in English
Note: Subject to FDA Import Alerts and Automatic Detention if facility has open Form 483 observations.
Regulatory information is provided for general reference based on publicly available FDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with FDA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Vancomycin from India and How Much Does EVERSANA Import?
India exported $27.4M worth of Vancomycin through 3,071 shipments from 318 suppliers to 140 countries, serving 743 buyers globally. EVERSANA imports $3.2M of this total, accounting for 2.3% of India's Vancomycin exports with 65 shipments from UNITED STATES. This is verified from 65 customs shipment records covering 20 distinct formulations.
What Is the Average Order Value for EVERSANA's Vancomycin Imports?
EVERSANA's average Vancomycin order value is $48.5K per consignment, based on 65 shipments totaling $3.2M. EVERSANA is based in UNITED STATES and ranks #3 among all Vancomycin importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Vancomycin to EVERSANA?
EVERSANA sources Vancomycin from 1 verified Indian supplier: GLAND PHARMA LIMITED ($3.2M, 100.0%). This is based on 65 customs records.
How Does EVERSANA Compare to Other Vancomycin Importers?
EVERSANA ranks #3 among 743 Vancomycin importers from India with a 2.3% market share. The top 3 importers are MYLAN INSTITUTIONAL INC 2898 ($5.8M), MYLAN INSTITUTIONAL INC ($4.4M), DR.FRIEDRICH EBERTH ARZNEIMITTEL ($3.3M). EVERSANA processed 65 shipments from UNITED STATES.
What Other Antibiotics Products Does EVERSANA Import?
EVERSANA also imports these antibiotics products. Each links to the detailed product page.
About EVERSANA
EVERSANA imports 12 products worth $27.6M. Beyond Vancomycin, top products include Heparin, Enoxaparin, Syringe, Sodium, Furosemide. View the complete EVERSANA profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Vancomycin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Vancomycin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: EVERSANA matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as EVERSANA's capped import value divided by total capped export value for Vancomycin across all Indian exporters.
- 5.Verified Records: This page is backed by 65 individual customs records matching EVERSANA importing Vancomycin, covering 20 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 140+ countries, 743+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Vancomycin Import Data for EVERSANA
Access order-level details, pricing data, supplier connections, and competitive analysis for EVERSANA's Vancomycin imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
EVERSANA
Full Company Profile →
12 products · $27.6M total trade · 9 categories
EVERSANA × Vancomycin
Verified from customs records
Company Overview
Top Products by EVERSANA
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for EVERSANA.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Vancomycin. For current order-level data, contact TransData Nexus.